Despite digital health’s potential, we're yet to see pharma use it successfully at scale. So, naturally, people across pharma are asking why they should continue to invest in digital health?
We’ve been tackling this question across a series of events this year. And the overwhelming conclusion from our HealthXL community, is that pharma can and should do digital better, to fully reap the rewards it can offer.
But first, they must move from opportunistic to truly strategic digital health initiatives to achieve scalable success.
In this report, experts from the HealthXL advisory team, pharma and digital health companies look at how this can be done via:
Building a framework for better digital health solutions
Determining the fit for digital health
Choosing success metrics that resonate
Rethinking internal resources and partnering for a successful ecosystem
Scaling with the right business models
Download now for the insights and guidance needed to lead pharma’s next digital health moves for real impact.
A special thanks to all our contributors:
Tessy Huss, Head of Market Research, HealthXL
Laura Ardill, Digital Health Insights Manager, HealthXL
Sarah Ann Kikkers, Digital Health Consultant, HealthXL
Jo Peddhinti, Director, Digital Health Advisory, HealthXL
Francesca Wuttke, CEO and Founder, Nen
John Cairns, Global Head of Digital, Oncology Franchise, Sanofi
Kal Patel, CEO and Co-Founder, BrightInsight
Rod Hughes, Executive Medical Science Director, AstraZeneca
Suhas Krishna, VP, Head of Product Management Digital Health, Bristol Myers Squibb
Anders Tveteraas, International Head of Patient Solutions and Services, Novartis
Amir Zur, Executive Director, Head of R&D Digital Health Products, Takeda
Alexander Klein, Group Leader Digital Health, Personalised Healthcare Center of Excellence, Roche Pharma
Matthew Bonam, VP, Head of BioPharmaceuticals R&D Digital Patient Health and Innovation, AstraZeneca
Sophie Park, Managing Director G4A Investments and Partnerships, Bayer
Karthick Kannan, Global Digital Health, Teva Pharmaceuticals
Ethan Wergelis-Isaacson, Director, Enterprise Strategy, McKesson
Alexander Condoleon, VP, Head of Digital Healthcare U.S., Sanofi